European patent application EP4496517A1, titled 'IN VIVO FLUID FLOW SENSOR,' has been published by the European Patent Office (EPO). The application was filed by Canary Medical Switzerland AG and lists Mark A. Adler, Steven Cazarez, and Jeffrey M. Gross as inventors. The patent relates to devices for monitoring fluid flow within the body, with IPC classifications including A61B (Diagnostic or Therapeutic Appliances) and A61F (Prostheses; Devices adapted for the introduction of therapeutic substances; Devices for the treatment of conditions of the vascular system).

This publication signifies the granting of a patent for a specific medical technology. While this is an intellectual property matter and not a direct regulatory mandate, it may impact companies operating in the medical device and prosthetics sectors by establishing exclusive rights for the patent holder. Companies developing similar in vivo fluid flow sensors should be aware of this patent to avoid potential infringement issues.